Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 380 participants.

Also called NCT03773822

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 380 participants (enrolled count) (from the registry)
Sponsor
CMC Ambroise Paré (from the registry)
Registry
  • NCT NCT03773822
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03773822. Randomized; double masking; primary purpose treatment. Start 2019-04-19 (actual); primary completion 2023-04-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.
Acronym
COCCA
Condition
Cardiogenic Shock
Intervention (Combination product)
Hydrocortisone + Flucortac
Intervention (Other)
Placebo
Lead sponsor
CMC Ambroise Paré (class: other)

Record details

Record id
cardio:ct-nct03773822
Content hash
9b49004194fb4f6adf6e8c2802f8382acdaa08280b12344dc8ee9576d283fc06